[Clinical management of pituitary prolactinoma from the perspective of obstetrics and gynecology: from reproductive health to lifespan care].
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
Pituitary prolactinoma is a common functional pituitary tumor with a high incidence in women of childbearing age, and its diagnosis and treatment are closely related to obstetrics and gynecology practice. "Consensus on the diagnosis and treatment of pituitary prolactinoma (2025 edition)" is based on evidence-based medicine and proposes systematic solutions to obstetrics and gynecology problems such as menstrual disorders, infertility, pregnancy safety, and lactation management. By constructing the path of abnormal menstruation-infertility assessment-pregnancy monitoring-postpartum management, a prolactinoma management model with obstetrics and gynecology needs as the main line is established. According to the high-quality evidence, it breaks through the traditional tumor-centered model and emphasizes the equal importance of reproductive health protection and tumor control. At the same time, the consensus clarifies the symptom-driven diagnostic pathway of obstetrics and gynecology (such as abnormal menstruation as an absolute indication for prolactin testing), the dynamic balance strategy of fertility management (such as microadenoma patients can try pregnancy during dopamine agonist therapy and stop the drug after pregnancy), a symptom-led monitoring system during pregnancy, postpartum management to support lactation, and a simplified long-term follow-up plan. It emphasizes the important role of obstetrics and gynecology in multidisciplinary diagnosis and treatment, providing a standardized and individualized decision-making framework for clinical practice.